Sensitivity | Specificity | PPV | NPV | |
---|---|---|---|---|
% (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
66-80 years old | 37.6 (36.6-38.6) | 97.1 (97.0-97.2) | 59.1 (57.9-60.4) | 93.3 (93.1-93.5) |
>80 years old | 28.4 (27.5-29.2) | 96.1 (95.8-96.3) | 74.5 (73.1-75.8) | 76.8 (76.4-77.3) |
Code Positive | Code Negative | |||
eGFR (mL/min per 1.73m 2 ) | Creatinine (μmol/L) | eGFR (mL/min per 1.73m 2 ) | Creatinine (μmol/L) | |
66-80 years old | 41 (29–55) | 133 (104–176) | 73 (60–85) | 81 (69–95) |
>80 years old | 34 (25–45) | 140 (109–183) | 58 (46–72) | 87 (71–106) |
Sensitivity | Specificity | PPV | NPV | |
% (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
Men | 43.7 (42.5-44.8) | 96.0 (95.8-96.2) | 62.0 (60.6-63.3) | 91.9 (91.7-92.1) |
Women | 25.7 (24.9-26.5) | 97.6 (97.5-97.7) | 69.4 (68.0-70.8) | 86.2 (86.0-86.5) |
Code Positive | Code Negative | |||
eGFR (mL/min per 1.73m 2 ) | Creatinine (μmol/L) | eGFR (mL/min per 1.73m 2 ) | Creatinine (μmol/L) | |
Men | 40 (28–53) | 145 (115–190) | 72 (59–83) | 90 (79–106) |
Women | 36 (25–49) | 123 (95–164) | 67 (53–81) | 74 (64–89) |